Podcasts about gsr ventures

About Yuechen Zhao :Yuechen is a Partner at GSR Ventures, where he focuses on early-stage investments in enterprise software and consumer platforms. Prior to GSR Ventures, Yuechen founded a personalized travel startup and built products at Google, Uber, and Meixin (fintech). Yuechen received his BA in Computer Science from Harvard University.Things You'll Learn:Despite public and private market fluctuations, a steady, long-view approach in investment strategy remains central, with a focus on substantive innovations with enduring value.Emerging AI technologies offer transformative potential in healthcare accessibility and patient empowerment.Successful investing is anchored in a decade-long commitment and the intimate support between founders and investors that goes beyond mere financial transactions.As investment climates shift and the health tech scene faces valuation declines, GSR Ventures strategizes to remain steadfast, resourceful, and committed to its portfolio companies.Entrepreneurs need market momentum and passion for problem-solving to sustainable business models that promise scalability and defensibility.Resources:Connect with and follow Yuechen Zhao on LinkedIn.Learn more about GSR Ventures on their LinkedIn and website.

A reminder for new readers. That Was The Week includes a collection of my selected readings on critical issues in tech, startups, and venture capital. I selected the articles because they are of interest to me. The selections often include things I entirely disagree with. But they express common opinions, or they provoke me to think. The articles are snippets sized to convey why they are of interest. Click on the headline, contents link, or the ‘More' link at the bottom of each piece to go to the original. I express my point of view in the editorial and the weekly video below.Hat Tip to this week's creators: @reidhoffman, @dougleone, , @credistick, @rex_woodbury, @NathanLands, @ItsUrBoyEvan, @berber_jin1, @cityofthetown, @keachhagey, @pmarca, @bhorowitz, , @signalrank, @steph_palazzolo, @julipuli, @MTemkin, @geneteare, @lorakolodny, @jasminewsun, @JBFlint, @asharma, @thesimonetti, @lessinContents* Editorial: * Essays of the Week* Crossing The Series A Chasm* The Consumer Renaissance* The Creator Economy on AI Steroids* AI Is Transforming the Nature of the Firm* The Opaque Investment Empire Making OpenAI's Sam Altman Rich* Video of the Week* The American Dream - Marc Andreessen and Ben Horowitz* AI of the Week* SignalRank Version 3 Improves Performance Again* How Long Can OpenAI's First-Mover Advantage Last?* OpenAI Employees Warn of Advanced AI Dangers* A Right to Warn about Advanced Artificial Intelligence* Nvidia hits $3tn and surpasses Apple as world's second-most valuable company* VCs are selling shares of hot AI companies like Anthropic and xAI to small investors in a wild SPV market* News Of the Week* Crunchbase Monthly Recap May 2024: AI Leads Alongside An Uptick In Billion-Dollar Rounds* Elon Musk ordered Nvidia to ship thousands of AI chips reserved for Tesla to X and xAI* Introducing video to Substack Chat* Instagram's Testing Video Ads That Stop You From Scrolling Further* Startup of the Week* NBA Nears $76 Billion TV Deal, a Defining Moment for Media and Sports* X of the Week* Doug Leone - I am supporting Trump. * Reid Hoffman - I am supporting BidenEditorialI woke on Tuesday to Doug Leone of Sequoia Capital on X saying:I have become increasingly concerned about the general direction of our country, the state of our broken immigration system, the ballooning deficit, and the foreign policy missteps, among other issues. Therefore, I am supporting former President Trump in this coming election.Doug has the right to support Trump. It is also clear that the immigration system is broken, the deficit is ballooning, many things are wrong with foreign policy, and there are “other issues.” Trump as the solution is less obvious. But there it is—hot on the tails of Chamath Palihipitaya and David Sacks announcing a fund-raiser for Trump on the All-In podcast (they said they would do the same for Biden).Reid Hoffman followed up a day later with:On one level, this is a straightforward choice, but any literate attempt to analyze Leone's issues might arrive at the following conclusions:* Like many Western nations, the USA is aging rapidly and has a shrinking working-age population across all skill sets. Immigrants are needed, and pro-immigration leadership is needed, creating a path to entry for large numbers of skilled and unskilled workers to fill empty jobs as we get close to full employment.* The deficit is large, and there are many palliatives available. Selling more to China would help, but both party leaders are protectionist. Taxes to reduce the divide between the 1% and the rest would help a bit. However, what would help the most is economic growth, which requires investment in technology and productivity. Neither leader seems too focused on innovation and investment.* Foreign Policy - well, sheesh, it's a big issue. However, saber-rattling about Taiwan and provoking China seems to be a hobby shared by both parties and does not seem smart. Ukraine and the future of Europe are better in Biden's hands, but not by a lot. Europe looks very shaky. The US is increasingly isolationist. The appetite for world leadership is on the decline. Again, the solution would focus on economic growth, which seems absent.Voting for Trump is a big no-no for me. But voting for Biden is, at best, a lesser evil instinct, not a belief system. The election will not be where the future is built, but it is important. Politicians are collectively disappointing.This week's video of the week from Marc Andreessen and Ben Horowitz is called “The American Dream” and champions their view about American Dynamism. And I must confess that this comes closer to a vision of the future than either political outfit. Their vision requires political support, massive government financial commitment, and private capital investment. I see no evidence of those happening.The real winning effort seems to be happening on the ground. This week, Nvidia hit $3 trillion, eclipsing Apple as the world's second-most valuable company. This is even though Apple has 7 times the revenue of Nvidia.This week's first essays also focus on prospects for boom time. Rex Woodbury's ‘The Consumer Renaissance' examines the impact of consumer spending on our lives. In ‘The Creator Economy on AI Steroids, ' Nathan Lands focuses on how emerging tools will transform creativity. But in ‘AI Is Transforming the Nature of the Firm, ' Evan Armstrong gets closest to a future vision.”AI is the first universally flexible technology. It can interact with our digital environments in similar ways to humans, so it can have all the flexibility that we do. In that way, it may be the last technology we ever need.This seems to be the crux of hope in a world where dreams and nightmares are strangely devoid of detail. What the world needs (not only America) is hope. And hope is born from optimism. Optimism is born from success. The most likely success of the next decades will result from specific uses of AI that improve human life.I know and like Doug Leone. I know and like Reid Hoffman. Doug's bar for success needs to be higher. Voting for Trump is not right, and even if it were, it would not be sufficient.Reid also needs a higher bar. Voting for Biden will not be sufficient even if it is right.Let's focus on where success can be found, grow optimism, and breed hope. There is a need for a broad technical revolution and the social rebirth it enables. Silicon Valley and its friends globally need to invent the next version of human existence to the benefit of all. The social rebirth requires a conscious effort; technology will not magically bring it about. More in this week's video.Essays of the WeekCrossing The Series A ChasmDan GrayDan Gray, a frequent guest author for Crunchbase News, is the head of insights at Equidam, a startup valuation platform, and a venture partner at Social Impact Capital.June 5, 2024As we get deeper into 2024, there is increasing concern about the state of Series A fundraising. The bar for investment appears much higher, and fewer startups are reaching it.This is a problem for founders, and investors like Jenny Fielding, managing partner of Everywhere Ventures, who said, “Every Seed investor's dilemma: All my Series A buddies want to meet my companies early! All my companies are too early for my Series A buddies.”To attach some data to this, we can see that the median step-up in valuation from seed to Series A has gone from $19.5 million in Q1 2022 to $28.7 million in Q1 2024. Series A firms seem to be looking for much stronger revenue performance, with targets of $2 million to $3 million in ARR, compared to $1 million to $2 million just a few years ago.The outcome is that while 31.8% of Q1 2020 seed startups closed their Series A within two years, that fell to just 12% for Q1 2022 — which should worry everyone.Why are Series A investors so much more demanding?Today's Series A investors are looking at startups that raised their seed between 2021 and 2023, which identifies the root of the problem: it spans the Q2 2022 high-tide mark for venture capital.For example, there were 1,695 seed rounds of more than $5 million in 2021, rising to 2,248 in 2022, then falling to 1,521 in 2023. As a comparison, there have been just 137 so far in 2024.The result is two categories of startups that are looking to raise their Series A today:* Pre-crunch startups that raised generous seed rounds and stretched the capital out as far as they could, to grow into inflated valuations.* Post-crunch startups that raised modest seed rounds on more reasonable terms, with shorter runways and less demonstrable growth.Strictly speaking, neither is more appealing than the other; the first group has less risk, the second offers more upside, and both are adapted to current market realities. It shouldn't cause a problem for investors, provided they can distinguish between the two.The cost of market inefficiencyVenture investors have a market-based lens on investment decisions, which means looking fairly broadly at trends in revenue performance and round pricing to determine terms, e.g. a typical Series A is within certain bounds of revenue performance and valuation. While that approach may be serviceable and efficient under ideal conditions, the past few years have been far from ideal.Without distinguishing between the two cohorts, investors are now looking at the performance of Series A candidates that spent more than $5 million on a war chest for two to three years of growth alongside the valuations of candidates that raised around $2 million to prove scalability. It just doesn't work as an average, and thus the unreasonable expectations...MoreThe Consumer RenaissanceFrom Predicting Consumer AI Applications to Analyzing Consumer SpendREX WOODBURY, JUN 05, 2024“Consumer” has become something of a bad word in venture capital circles.We see this reflected in the early-stage markets: recent data from Carta showed that just 7.1% of Seed capital raised last year went to consumer startups. That's less than half the share from 2019 (14.3%).But I think consumer is actually a great place to be building and investing. Whenever something is out of favor, that's a sign it's probably a good place to spend time: this is an industry built on being contrarian, not built on following the herd. We're entering a compelling few years for consumer entrepreneurship.First, I'd argue that consumer is too narrowly defined. When people think consumer, they often think consumer social (a tough category) or consumer brands (a tough fit for venture compared to internet and software businesses, with typically lower return profiles). But consumer is broader. Consumer encompasses businesses that sell to consumers and those that rely on consumer spending. This means the obvious names—apps on our phones like Uber, Instacart, Spotify—and the enablers: Shopify, for instance, powers online retail; Faire powers offline retail; Unity powers game development. Each of the latter three is B2B2C, in its own way, but I would categorize each is also a consumer technology business.The wins in consumer can be massive. The biggest technology businesses in history began as consumer businesses—Google, Facebook, Apple, Amazon. The original companies comprising FAANG—with Microsoft conspicuously absent—were allconsumer.And some of the best returns of the last five years have stemmed from consumer tech IPOs. At Daybreak, we invest ~$1M at Pre-Seed and Seed. Here's how much a $1M investment in the Seed round of five recent consumer IPOs would yield:Big consumer wins compare favorably to big enterprise wins—relative to Snowflake's market cap, Uber is ~3x in size, Airbnb is ~2x in size, and DoorDash is roughly equal. (Snowflake is the biggest enterprise IPO of the last decade.) The last few years produced a windfall of consumer outcomes, yet investors today almost write off the category.At Daybreak, we don't focus exclusively on consumer; my view is that you need to balance more binary consumer outcomes with B2B SaaS and B2B marketplaces. But we do approach investing through the lens of the consumer—how people make decisions. The buyers of products like Figma and Ramp, after all, are people, and software companies are increasingly selling bottom-up into organizations. The line between consumer and enterprise has been blurring for years.This week's Digital Native makes the argument that consumer tech is a compelling place to build and invest. We'll look at the data to back up this argument, then delve into three categories of consumer that I'm particularly interested in right now:* Checking in on Consumer Spend* Consumer Tech: The Data Doesn't Lie* What to Watch: AI Applications* What to Watch: Shopping* What to Watch: Consumer Health* Rule of Thumb: Follow the SpendThis week we'll cover #1-3, and next week in Part II we'll tackle #4-6.Let's dive in

Host Justin Barnes, aka the @HITAdvisor, is at HLTH 2023 creating October as Healthcare/ Digital Health Thought Leadership Month. His guests on this episode are Justin Norden, MD MBA, Partner at GSR Ventures and John Halamka, MD, MS, President of the Mayo Clinic Platform. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Generative AI - a subset of AI technologies that employ advanced machine learning algorithms to generate content, solutions, or outcomes that weren't explicitly programmed into the algorithms has many potential applications in healthcare. But at the moment, the digital health space is filled with noise. This discussion was recorded at HLTH 2023 in Las Vegas. Justin Norden - Partner at GSR Ventures talks about: his observes from the investor's perspective, what he thinks about the discussions on open-sourced vs. closed AI development, why everyone should incorporate generative AI in healthcare and more. Newsletter summary of generative AI in healthcare: https://fodh.substack.com/p/generative-ai-in-healthcare Interview with Justin Norded - July 2023: https://www.facesofdigitalhealth.com/blog/investors-bet-on-in-generative-ai-in-healthcare https://www.facesofdigitalhealth.com/

Addressing Medicine's AI Disconnect Dr. Justin Norden, adjunct professor at Stanford Medicine and a partner at GSR Ventures, recently put out the first-ever collaborate state of healthcare generative AI report, and he helps us understand what's possible from this emerging tech class to help consumers in their health journeys.  All that, plus the Flava of the Week about Amazon's new insulin coupons. What does this latest battle in the War for Drug Pricing signal about Amazon's healthcare roadmap, and how can we come together to increase the consumer-minded innovation that happens in other steps of the consumer journey?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Dr. Justin Norden, adjunct professor at Stanford Medicine and a partner at GSR Ventures, recently put out the first-ever collaborate state of healthcare generative AI report, and he helps us understand what's possible from this emerging tech class to help consumers in their health journeys.  All that, plus the Flava of the Week about Amazon's new insulin coupons. What does this latest battle in the War for Drug Pricing signal about Amazon's healthcare roadmap, and how can we come together to increase the consumer-minded innovation that happens in other steps of the consumer journey?  This show is produced by Shift Forward Health, the channel for change makers. Subscribe to Shift Forward Health on your favorite podcast app, and you'll be subscribed to our entire library of shows. See our full lineup at ShiftForwardHealth.com. One subscription, all the podcasts you need, all for free. (#283)See omnystudio.com/listener for privacy information.

Generative AI is definitely the word we will remember 2023 by. Knowing that administrative burden is among the key reason for physician burnout, the idea that AI could tackle this challenge, became a little bit more tangible with the raised awareness and public understanding of generative AI. But where are we exactly, and how is generative AI utilized for clinical use cases, administration, patient care and in biotech?  GSR Ventures and Maven Ventures are two health technology-focused VC firms that analyzed 145 startups across healthcare delivery and life sciences with generative AI solutions. They highlighted their innovations, challenges, and market potential. Collectively, the startups have earned more than $20 billion in funding and have 47,000 employees. I had the pleasure to chat with Partner at GSR Ventures Justin Norden about the report and details such as: why has biotech raised the most so far, why not are startups working on the administrative issues, how do investors look at liability issues with generative AI, and what exactly are they looking for in startups, apart from a great team?  Full generative AI companies in healthcare report: https://aicheckup.substack.com/p/where-generative-ai-meets-healthcare www.facesofdigitalhealth.com Newsletter: fodh.substack.com SPONSOR: Magic Mind Go to magicmind.com/digitalhealth use the code DIGITALHEALTH20 to get a discount on your purchase

Thanks to our guest today, #TheShot of #DigitalHealth Therapy has been augmented by Fireflies.ai - Jim Joyce and I had the plasure of hosting the awesome Justin Norden, MD, MBA, MPhil, Partner at GSR Ventures:

On this special episode hear these selected interviews from Justin's show at ViVE 2023 in Nashville: Dr. Roxie Mooney, Digital Health Advisor and best selling author, Justin Norden, MD, GSR Ventures, and Therasa Bell, Co-founder, President, and CTO, Kno2. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.” Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Host Dr. Nick van Terheyden aka Dr. Nick, discusses From Microsoft to Medicine: The Journey of a Tech-Savvy Doctor Who Won't Let Chat GPT Make His Bed (Yet) with Justin Norden, MD, Partner at GSR Ventures. Their discussion includes ChatGPT4 passed the medical exam for doctors (Step 2), what does this mean for medicine, medical school, and the delivery of healthcare, highlights the excitement and fear surrounding the capabilities of ChatGPT, need for better benchmarks and safety measures to ensure its reliability and effectiveness. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.” Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

April 5: Today on the Conference channel, it's an Interview in Action live from ViVe 2023 with Justin Norden, Partner at GSR Ventures, and Michael Hasselberg, Chief Digital Health Officer at University of Rochester Medical Center. What's the best way to approach creating an investment arm in a health system? How can startups be coached during a partnership to make sure they don't lose their way? What technology are they looking to in the next couple of years for impactful innovation in the healthcare space?We understand that staying ahead of the curve regarding Security Priorities can be challenging. Join us, April 6, 1:00pm, for this webinar to learn how CISOs in healthcare address Security Priorities for 2023 – insights that can help keep your healthcare organization safe and secure. https://thisweekhealth.com/ciso-priorities-2023/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Through the adoption of AI,  the expanded use of technology, and the application of data, digital health investors are making healthcare more accessible, affordable, and easier for everyone involved - from the patients to those administering the care. In this episode, I chat with Justin Norden, Partner at GSR Ventures, who invests in digital health companies.Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo. Additionally, he worked on the healthcare team at Apple, co-founded Indicator - an NLP based platform for biopharma decision making, and helped start the Stanford Center for Digital Health. As an academic he is an award winning machine learning and bioinformatics researcher with 20+ publications. Finally, Justin is a former professional athlete and 3x world champion in ultimate frisbee. Justin received his MD from Stanford University School of Medicine, MBA from the Stanford Graduate School of Business, Master of Philosophy in Computational Biology from the University of Cambridge, and BA in Computer Science from Carleton College.

What does it take to lead a health department with a budget of more than $50 billion, overseeing the health of nearly 20 million Americans? Here to tell us about that is Dr. Nirav R. Shah, who was the 15th New York State Commissioner of Health from 2011 to 2014. Today, Dr. Shah is a nationally recognized advocate of patient safety, health care innovation, and high-quality, low-cost care. He has variously served as Chief Operating Officer of Kaiser Permanente in Southern California, Advisor to the CDC Director, Senior Fellow of the Institute of Health Improvement, and Senior Scholar at Stanford University's Clinical Excellence Research Center. In this episode, Dr. Shah joins us to share his philosophy of healthcare leadership and how meaningful relationships anchor his work.In this episode, you will hear about:How Dr. Shah's upbringing and the influence of Jainism steered him away from a lucrative career in finance and into medicine - 1:53Two patient stories in which seemingly simple mistakes led to moments of awakening for Dr. Shah in recognizing his purpose in medicine - 6:21A brief overview of Dr. Shah's career path - 13:47Lessons on empathetic leadership that Dr. Shah picked up along the way - 19:21How forging strong relationships helped Dr. Shah find solutions on big issues during his time as New York State's Health Commissioner - 21:57Dr. Shah's current pursuits, including those focused on making a business case for supporting the unpaid caregivers of patients - 31:23Why transparency and bureaucratic structure are critical components of healthcare reform in the United States - 37:46Advice to clinicians on what makes effective leaders and collaborators, and how to find passion for meaningful projects - 41:43Dr. Shah is a trustee of the John A. Hartford Foundation, a board member of STERIS, and an advisor to GSR Ventures.You can follow Dr. Nirav R. Shah on Twitter @NiravRShah or on LinkedIn.Visit our website www.TheDoctorsArt.com where you can find transcripts of all episodes.If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2023

December 27: Today on the Community channel, it's an Interview in Action live from HLTH ‘22 with Justin Norden, MD, Partner at GSR Ventures. What kinds of investments are health tech focused venture funds making in this current market?

While digital technologies now permeate nearly every aspect of our lives, its application to improve medicine remains limited. Still, recent advances in artificial intelligence, telecommunications, and other technologies hold enormous potential to transform how healthcare is delivered. At the forefront of exploring this potential is Dr. Justin Norden, a physician and investor at the venture capital firm GSR Ventures, where he focuses on investments in digital health companies. With a background in computer science, Dr. Norden previously worked on the healthcare team at Apple and helped launch the Center for Digital Health at Stanford University. He joins us in conversation to discuss how he discovered investing and entrepreneurship as a way to tackle problems in medicine, clarify misconceptions about digital health and venture capital, and explore how technologies are shaping the future of medicine.In this episode, you will hear about:A brief introduction to venture capital - 1:48How Dr. Norden's experiences during medical training led him explore entrepreneurship and healthcare investing - 3:22How Dr. Norden's passion for computer science influenced his medical education - 7:30What it was like to leave a clinical career - 10:18The past and current state of technological advancement in medicine - 20:28Co-host Dr. Johnson's concerns over the ways technology has, at times, impeded the delivery of health care - 28:38Dr. Norden's vision for the ideal balance between humanism and technology in medicine - 34:31How Dr. Norden considers the reconciliation between the profit motive of companies and the preservation of what makes medicine meaningful - 38:28How Dr. Norden decides which digital health companies to invest in - 44:57Advice to young clinicians who are curious about healthcare innovation - 50:09Follow Dr. Norden on Twitter @JustinNordenMD.Visit our website www.TheDoctorsArt.com where you can find transcripts of all episodes.If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2022

Sunny Kumar is a Partner at GSR Ventures, where he focuses on investments in early-stage companies applying artificial intelligence and machine learning technologies to the healthcare sector. He is a physician as well as a published medical researcher with a focus on applying informatics and artificial intelligence to translational medicine in the fields of neurosurgery and gene therapy.He is a serial entrepreneur and most recently founded a company to reduce readmissions for high-risk patients with chronic diseases using voice-enabled natural language processing technology. Sunny received a BS in Molecular Biology from Yale University, an MD from Stanford University School of Medicine, and an MBA from Stanford University Graduate School of Business.During this episode, you will learn about;[00:00] Episode intro and a quick bio of the guest; Sunny Kumar[01:47] How Sunny began in medicine and venture capital investing[09:40] At what point in life did Sunny have a pivotal moment from clinical to technical[12:40] How he overcame the fear of the unknown from a stable job to entrepreneurship[16:14] How you can protect yourself from moral injury and burnout crisis in medicine[17:14] How he found a job that matched what he wanted to do from being a doctor[24:40] ROIs for deals that are invested by venture capital[27:20] What Sunny looks for in a founder that gives him the confidence to invest[29:20] Sunny's advice to new CEOs as the business begins to scale up[35:07] Benchmarks you can use to guide the conversation in startup investing[39:05] Sunny's advice on how you can take your business idea to the next step[46:25] What he wishes to have spent more time and resources on[47:32] Ending show and call to actionNotable Quotes● Medical doctors sometimes find it hard to get used to the entrepreneurship life oflearning through failures. They are always trained to be right and never fail. [23:53]● Before investing in venture capital, understand that companies are different andindependent. You must learn to cope and grow with the company at every step. [28:05]● A successful company is based on strong management and a great team. [29:40]● There are many services set aside for early startup companies. They are highly offeredin a subsidized manner. [39:17]Connect With Sunny KumarWebsite: https://gsrventuresglobal.com/LinkedIn: https://www.linkedin.com/in/sunnykumar1/

Host Justin Barnes, aka the @HITAdvisor's guest is digital health venture capital investor and Partner at GSR Ventures, Justin Norden, MD MBA. With a philosophy that technology can fundamentally change the delivery of healthcare, GSR Venture has $3.5B under management that focuses on early stage investing in health technology. Hear what gets this venture fund excited to invest in. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden. Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health. In this episode, we cover: The Healthcare Thesis at GSR Ventures Virtual Reality (VR) Digital Therapeutics Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx What it would take to scale existing Prescription Digital Therapeutics The Role Of Health Coaching alongside AI automation The Drivers of Success Going Forward for the Digital Therapeutics Market Guest Links and Resources: Connect with Justin Norden on LinkedIn | Twitter Visit https://gsrventuresglobal.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Changing paths is never easy, but if that decision allows you to generate a transformational impact that can benefit millions of people, then it's worth a try. In this episode, Dr. Sunny Kumar, Partner at GSR Ventures joins the show to share his entrepreneurial journey and talk about how to make the medical field a more versatile and innovative space. Plus, Sunny talks about his role in GSR Ventures and why New Haven's style pizza deserves more praise! JUMP STRAIGHT INTO: (00:47) - Sunny's first approach to entrepreneurship and how it relates to innovation - “We had discovered that with the closure of one of the largest grocery stores in the area, there was no access to fresh fruit for all of downtown New Haven.” (04:36) - The first pivotal moments that led Sunny into the healthcare path - “While I loved the basic science, I found the application to medicine -to the human impact that came with that- to be incredibly rewarding.” (09:25) - Connecting research with business: Sunny's MBA experience inside Stanford GSB - “These emerging technologies looked like they could dramatically change how medicine was trained and practiced. How patients interact with their physicians. But this has not yet been widely adopted.” (19:48) - Wave Medics: The story of Sunny's second startup - “The beauty of this was that you could use the smart speaker to interact with the patient, collect information, a process that information and then use that processed information to guide treatment.” (26:30) - Transformative impact: Sunny's advice for people thinking about switching their career paths - “I believe many of our programs can put trainees down a relatively narrow path without a lot of visibility into what those alternatives may be.” (33:12) - A phase of change: What does the medical path need in order to become more versatile? - “Most of medicine is done in an institutional setting where administrative decisions aren't made by the physicians. My view of the world is that physicians are increasingly recognizing that.” (37:06) - What is GSR Ventures and how is Sunny helping them grow? (+Pizza talk!) - “I work with companies that are raising anywhere between a million dollars to $15 million from us with the goal of building technologies that are going to have a transformative impact in healthcare.” EPISODE RESOURCES:  Connect with Sunny on https://www.linkedin.com/in/sunnykumar1/ (LinkedIn)  Learn more about https://gsrventuresglobal.com/details/sunny-kumar (GSR Ventures)  Thank you for listening! Don't forget to subscribe, rate and share the show wherever you listen to podcasts!  The Slice is produced by Sterling Shore and Rachael Roberts at https://www.studiopodsf.com/ (StudioPod Media), and Shauna Davis at https://www.ossovr.com/ (Osso VR). Engineered by https://nodalab.com/ (nodalab).

In this episode, Justin Norden, Partner at GSR Ventures, shares his personal story to inform the investment thesis behind GSR Ventures' health tech-focused venture fund. Justin is both a physician and a computer scientist by training and has a real passion for the Medicaid sector. He discusses the many challenges in healthcare for startups and […]

In this episode, Justin Norden, Partner at GSR Ventures, shares his personal story to inform the investment thesis behind GSR Ventures' health tech-focused venture fund. Justin is both a physician and a computer scientist by training and has a real passion for the Medicaid sector. He discusses the many challenges in healthcare for startups and […]

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

Dr. Justin Norden is a Partner at GSR Ventures, a healthcare technology-focused venture fund investing in early-stage companies that are leveraging emerging technology to drive transformative changes in healthcare for all patients.   Justin explains, "Digital health has been, I think, a long journey for companies really trying to find things that we know should work, that we've seen work in other aspects of business where technologies really transformed how we do things. Even though that technology has been possible, it really hasn't touched healthcare until many would argue, very recently." "Many companies that came in, either starting around 2010 or even through 2015, were a lot of the similar ideas that we're seeing today, there just wasn't the adoption. We didn't see patients being ready to adopt these technologies. Largely, even though some patients tried to adopt them, the providers weren't ready, providers weren't ready to deal with that data or willing to connect or spend time with the patients using these new technologies." "In terms of how my background fits into how I look at companies today, I think one of the things that's very clear is if you go through medical training with a computer science background, you're continually banging your head against the wall saying why are we doing this repeatable task? Why are we using fax machines?" #GSRVentures #DigitalHealth #MobileHealth #HealthTech #Healthcare #VirtualHealthcare #VentureCapital #HealthTechDeals GSRVenturesus.com Listen to the podcast here

Dr. Justin Norden is a Partner at GSR Ventures, a healthcare technology-focused venture fund investing in early-stage companies that are leveraging emerging technology to drive transformative changes in healthcare for all patients.   Justin explains, "Digital health has been, I think, a long journey for companies really trying to find things that we know should work, that we've seen work in other aspects of business where technologies really transformed how we do things. Even though that technology has been possible, it really hasn't touched healthcare until many would argue, very recently." "Many companies that came in, either starting around 2010 or even through 2015, were a lot of the similar ideas that we're seeing today, there just wasn't the adoption. We didn't see patients being ready to adopt these technologies. Largely, even though some patients tried to adopt them, the providers weren't ready, providers weren't ready to deal with that data or willing to connect or spend time with the patients using these new technologies." "In terms of how my background fits into how I look at companies today, I think one of the things that's very clear is if you go through medical training with a computer science background, you're continually banging your head against the wall saying why are we doing this repeatable task? Why are we using fax machines?" #GSRVentures #DigitalHealth #MobileHealth #HealthTech #Healthcare #VirtualHealthcare #VentureCapital #HealthTechDeals GSRVenturesus.com Download the transcript here Download the transcript here

Why is there a mismatch between VC companies and some vulnerable patient populations? Do we need a radical transformation from the ground up of the medical curriculum? Are there any similarities between clinical and athletic training and investing? In this episode, we answer all of these questions and more with our guest, Justin Norden, MD. Justin is a Partner at GSR Ventures, where he focuses on early-stage investments in digital health, AI/ML in healthcare, and enterprise technology. Justin received his MD from Stanford University School of Medicine, MBA from the Stanford Graduate School of Business, M.Phil in Computational Biology from the University of Cambridge, and BA in Computer Science from Carleton College.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

This episode features Dr. Justin Norden, Partner at GSR Ventures. Today, he expands on the evolution of his career, how tech enabled services have changed since the pandemic, what can be done with medical residency programs to attract more people and prevent early burnout, plus much more.

Artificial intelligence and machine learning have widespread potential in healthcare, from diagnostic analysis and clinical decision support to data management and patient engagement. On today's episode, GSR Ventures partners Sunny Kumar and Justin Norden join host Laura Lovett for a far-reaching discussion of what they're seeing in the world of healthcare AI.Talking points:What investors are looking at/for in AILow hanging fruits and hard problemsAI is not currently about replacing doctorsAI's potential for mental healthHow AI can make medicine more, not less personalThe lack of innovation in clinical trials and how it's changingCulture clash in healthcare and startupsRegulatory updates and reimbursement challengesThe present and future of digital therapeuticsHealth equity and value-based careDriving efficiencies in care and looking for the next telemedicineMore about this episode:Healthcare innovation, digital health rake in big investment dollars in Q3Q&A: Deloitte's Peter Micca on the digital health investment boom, going public and value-based careAI development must be guided by ethics, human wellbeing and responsible innovationHow CIOs are prioritizing AI investments for the next 5 yearsAI and the tradeoff between fairness and efficacy: 'You actually can get both'

In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending August 27. There were 87 deals over the past 5 days where Chinese startups raised US$2.71 billion. Startups like Kuaikan Manhua, XREX and Ionova Life Science all raised large amounts of capital, and over 370 venture capital and private equity firms got a taste of those 87 deals. Investors in this week's deals include Shenzhen Capital Group, Greater Bay Area Homeland Development Fund, GSR Ventures, Tsing Song Capital, Systex Corporation, Metaplanet Holdings, Sequoia Capital China, Qiming Venture Partners, and FountainBridge Capital. Be sure to subscribe to China Money Podcast for free in the iTunes store, or subscribe to our weekly newsletter.

#THCBGang will feature special guest venture capitalist and massive over-achiever Justin Norden (@JustinNordenMD) from GSR Ventures. Also joining Matthew Holt (@boltyboy) will be regulars, patient safety expert and all around wit Michael Millenson (@MLMillenson); WTF Health host and Health IT girl Jessica DaMassa (@jessdamassa); futurist Ian Morrison (@seccurve); and THCB regular writer Kim Bellard (@kimbbellard)

In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending April 16. We are at the midpoint of the month of April, and we recorded 58 different startup, growth stage, and pre-IPO investment deals closing in the past 5 days totaling US$1.5 billion. Investors such as Sequoia Capital China, Tencent Holdings, Nio Capital, GSR Ventures, Cygnus Equity, C Ventures, BAI, CITIC PE, and Northern Light Venture all made investments this week in a wide range of companies like China's version of the U.S.-based Peloton and a cancer screening startup. This is the April 16, 2021 edition of the China Money Podcast where we update you on the news, data, and insights you need for making private equity and venture capital decisions in China. Be sure to subscribe to China Money Podcast for free in the iTunes store, or subscribe to our weekly newsletter.

Peng is the Co-Founder and Managing Partner at Monk's Hill Ventures, a venture capital firm investing in early-stage tech companies, primarily Series A, in Southeast Asia. Peng is an industry veteran with over 25 years of experience as an entrepreneur, founder, and investor in Silicon Valley and in Asia. He is based in Indonesia and is a board member of Glints, ELSA, Finaxar, and Intelligent Video Solutions.Prior to Monk's Hill Ventures, he was a Venture Partner at GSR Ventures in China. The firm is known for its successful investments in companies like Didi Chuxing and Qunar. As an entrepreneur, he co-founded a series of successful companies including Electric Classifieds (today known as Match.com), Interwoven and Encentuate, which combined today generate over USD$1 billion in revenues annually.Peng is currently the Chairman of SolveEducation! and serves as a board member of the International Advisory Board for the University of Texas at Austin and SEA Founders.Peng earned a B.S. in Electrical Engineering from the University of Texas and an M.S. in Computer Science from the University of Illinois.Key TakeawaysWhy the best investment Peng has made is being an entrepreneur and how that helped him as an investorWhat is first principles thinking and how founders must use the framework while building startupsWhat questions should you as a founder ask a VC while pitching to themWhat stage a startup must be in terms of product, distribution, and team to successfully raise a Series A roundHow Monk's Hill Ventures support their portfolio companies in scaling their businessesImportance of Board of directors in the success of a startupStrategies startups use while expanding their business to different countries in Southeast AsiaWhy artificial intelligence and bioengineering are the most important technologies for the future of mankind

We are very honoured to invite Peng T. Ong, co-founder and managing partner of Monk's Hill Ventures, to join our first episode of Asia Startup Pulse today. Monk's Hill Ventures is a venture capital firm investing in early-stage tech companies, primarily Series A, in Southeast Asia. Peng is an industry veteran with over 25 years of experience as an entrepreneur, founder, and investor in Silicon Valley and in Asia. He is based in Indonesia and is a board member of Glints, ELSA, Finaxar, and Intelligent Video Solutions. Prior to Monk's Hill Ventures, he was a Venture Partner at GSR Ventures in China. In this episode, we talk about Peng's journey as an investor and how he perceives the great potential in Southeast Asia. More importantly, he summarizes a very important trend in SEA's startup ecosystem, "Technification". We also talk about the impact that China's Internet giants have on SEA through investments and M&A.Show Notes:1:54 Peng's journey as an investor3:22 Main differences btw seed round and Series A9:15 More capital investment in SEA10:20 The most interesting trend in SEA10:56 “Technification” in China12:24 The opportunities of “technification” in SEA14:33 “There is no way for a company to grow that fast without technology”17:31 The core DNA of a successful founding team18:54 China's role in SEA's service industry22:22 The role of Chinese and Japanese corporate venture capital in SEA26:20 The infrastructure development in SEA28:25 A hard push on deep technology in SEA?Many thanks to our guest Peng T.Ong; host Oscar Ramos; producers Eva Shi and Sagar Chaudhary; editor David; organizer Chinaccelerator; and sponsor People Squared. Be sure to check out our website www.chinaccelerator.comShare, subscribe, review, enjoy!Follow us on LinkedIn: https://www.linkedin.com/company/asia-startup-pulseEmail us: team@chinastartuppulse.com

In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending March 12. We are nearing the ides of March 2021, and in the past 5 business days we counted over 70 deals closing with private equity and VC firms in China with a combined raise of more than US$2.3 billion in everything from seed to pre-IPO rounds. And one firm even raised a whopping 700 million in its Series A, while we saw other news concerning Huawei, AstraZeneca, and Xpeng Motors dominate the investment headlines. Startups in China this week raised funding from over 250 corporate venture capital, private equity and regular venture capital firms like Matrix Partners China, Hillhouse Capital, Warburg Pincus, Shenzhen Capital Group, Lilly Asia Ventures, Hina Group, Fengrun Investment, New Hope Group, Xiaomi, Fuho Capital, Meridian Capital, FutureX Capital, Addor Capital, GSR Ventures, Cowin Capital, Brill Capital and many others. Matoka Capital's Danny Levinson sits in as guest host this week too. Be sure to subscribe to China Money Podcast for free in the iTunes store, or subscribe to our weekly newsletter.

In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending February 26. This was a massive week for China's venture capital and private equity investors as well as the startups and businesses that closed their funding rounds. We documented 99 deals that closed this week, and those deals totaled more than 3.204 billion US dollars. Just a massive week of dealflow across China! Key investors making commitments in China this week included Temasek Holdings, GGV Capital, Zhen Fund, BAI, GSR Ventures, Huaxing New Economic Fund, Lightspeed China Partners, Sequoia Capital China, Millennium Capital, and Oceanpine Capital. Be sure to subscribe to China Money Podcast for free in the iTunes store, or subscribe to our weekly newsletter.

Overview Jason A. Duprat, Entrepreneur, Healthcare Practitioner and Host of the Healthcare Entrepreneur Academy podcast talks to Dr. Justin Norden, partner at GSR Ventures. As a serial entrepreneur, Justin talks about healthcare technology, how you should execute your business idea, and how to look for the right investors for your company.   Episode Highlights Justin discusses his atypical medical school journey at Stanford and how he transitioned to business school with a focus on entrepreneurship. How did Justin get involved with healthcare technology innovation? How can you best prepare when it comes to building your own company and seeking funding?  Four areas are transforming how healthcare is delivered: data, EMR, AI and ML (machine learning). Several companies are making waves in the healthcare landscape, like Kinsa, Medable and Alpha Medical. When is the right time to invest to make physical prototypes? Hone your business ideas and execute them through hard work. Seek out negative feedback as an entrepreneur.  Justin provides an overview on the pros and cons of kickstarters and investors.  What it’s like to pitch your ideas to interested investors?  When you do meet with investors, share your pitch deck and be prepared to make the ask.   Utilize good data to make predictions and to make good things happen.  Justin shares his thoughts on what the future of healthcare technology might look like  years from now.   3 Key Points Everything in healthcare moves slow, especially with the current pandemic. Although this may be the case, there are still people like Justin and companies like GSR Ventures that aim to innovate healthcare technology, as well as provide a better quality of life for both healthcare practitioners and patients. If you have an idea and want to start a company, figure out what stage you’re at. Starting a business is all about the execution of ideas, the hard work you put into it and finding someone who’ll invest in your vision. Approaching interested investors isn’t like what you see on TV. The most important thing is getting your idea out there and getting everybody on board - you simply need to get to that first investor. Tweetable Quotes “Keep trying…talk to as many people as you can. Get feedback from your colleagues, from others, from your patients. Understand and validate as much as you can.” - Dr. Justin Norden   “You should expect to meet with tens, if not hundreds, of investors before people will end up funding something.” - Dr. Justin Norden   “Just try to get real feedback from them…I think that’s such an important thing as an entrepreneur, and you can never get too much.” - Dr. Justin Norden   References Mentioned Dr. Justin Norden on Linkedin - https://www.linkedin.com/in/justin-norden GSR Ventures Website - https://gsrventuresglobal.com/ Kinsa Website - https://www.kinsahealth.co/ Medable Website - https://www.medable.com/ Alpha Medical Website - https://www.helloalpha.com/   #HealthcareEntrepreneurAcademy #healthcare #entrepreneur #entrepreneurship #startup #smallbusiness #venturecapital #healthcaretechnology #innovation

In this episode, we are privileged to feature Dr. Sunny Kumar, a partner at GSR Ventures, physician, and serial entrepreneur. GSR Ventures is a venture capital firm focused on early-stage companies developing AI-enabled enterprise software, consumer platforms, and healthcare technology. Sunny discusses how his company is helping start-up companies that bridge both tech and health care ecosystems by providing financial support and spending time with them. He shares crucial product pricing information, insights on investing, the impact of COVID-19, the value of solving customer's problems, and more. This has been a fascinating interview where you'll get a lot from the discussion, so please tune in! https://outcomesrocket.health/gsrventures/2020/11/

Sunny Kumar, Partner at GSR Ventures talks about the healthtech field. How can founders overcome multiple regulation barriers and get through the capital-intense field? How should they get in touch with the right people in healthtech space if they don't have the right network? Sunny's choice of newsletters that he recommends Fundraising Radio's listeners to follow (I like those too!) - StrictlyVC (VC) Axios Pro Rata (VC) CB Insights Newsletter (VC/Health/Fintech) Fortune Brainstorm + Emerging Tech Newsletter (Health) Rock Health Newsletter (Health / VC) Seeking Alpha Morning Newsletter (General) Morning Brew + Emerging Tech Newsletters (General / Tech / VC) Accelerated (VC / Tech) Sunny's LinkedIn: https://www.linkedin.com/in/sunnykumar1/ GSR Ventures: https://www.gsrventures.com/

David Rosenberg is the cofounder and CEO of AeroFarms which is an urban cleantech company that provides aeroponic growing systems to produce plants without sun or soil. The company has raised over $200 million from top tier investors which include GSR Ventures, Newark Venture Partners, Middleland Capital, 21Ventures, Wheatsheaf Group, MissionPoint Capital Partners, Cibus Fund, and ADM Capital to name a few.

David Rosenberg is the cofounder and CEO of AeroFarms which is an urban cleantech company that provides aeroponic growing systems to produce plants without sun or soil. The company has raised over $200 million from top tier investors which include GSR Ventures, Newark Venture Partners, Middleland Capital, 21Ventures, Wheatsheaf Group, MissionPoint Capital Partners, Cibus Fund, and ADM Capital to name a few.

Learn more about GSR Ventures by visiting: http://www.gsrventures.com/en

Yinglian Xie is the co-founder and CEO of DataVisor which is a fraud detection company powered by transformational AI technology. The company has raised $100 million from investors like NEA, Sequoia, GSR Ventures, and Genesis Capital. 

Yinglian Xie is the co-founder and CEO of DataVisor which is a fraud detection company powered by transformational AI technology. The company has raised $100 million from investors like NEA, Sequoia, GSR Ventures, and Genesis Capital. 

Minister Tharman Shanmugaratnam, chairman of the Monetary Authority of Singapore recently hailed new virtual bank licences as the next chapter in Singapore's banking liberalisation journey. Virtual banking seems to represent a new chapter in Singapore’s journey as a world-class financial hub, it is also an important milestone in the city-state’s ambitions to be a leading artificial intelligence (AI) hub. AI is playing an increasingly important role in global banking operations across areas such as with Know Your Customer (KYC), anti-fraud, and credit scoring solutions. Jefferson Chen, CEO of ADVANCE.AI, and also a Partner at GSR Ventures, a leading venture capital firm in China who was the first investor in “unicorn” internet companies explains more. 

Join us today as we speak with Sunny Kumar from GSR Ventures about how A.I. and other emerging technology is at the cusp of transforming health

Following a successful career at Google Japan, Renee Wong left to start Castbox 3 years ago. It’s an award-winning global podcast platform that enables anyone to easily find, access, create, and enjoy spoken audio content. (I’m a fanboy.) Castbox’s proprietary technology includes cool features like curated podcast recommendations & in-audio deep search to customize your listening experience. With 40 employees in Beijing, Palo Alto, and Hong Kong, Renee’s riding a the very big wave of podcasting. And investors are taking notice… She’s raised millions in venture capital from GV (Google’s venture capital arm), Qiming Venture Partners, IDG Capital, SIG China, GSR Ventures, and ZhenFund. In this 20-minute episode, Renee reveals how she leads a distributed team that literally spans the globe. (And you think you’ve got leadership challenges?…)

The Internet age has brought with it the “New Four Great Inventions” of China: high speed trains, scan-and-pay mobile payments, bike-sharing, and ecommerce. This week's episode is the first in a two-part story on bike-sharing-- told against a backdrop of Ofo, one of the two major Chinese players, pulling out of international markets. What happened? And most importantly, what is happening now? Listen to this week's episode of TechBuzz China by co-hosts Ying-Ying Lu and Rui Ma, for a history lesson on Ofo! Guest speaker Karl Ulrich, the Vice Dean of Entrepreneurship and Innovation at the Wharton School, weighs in as well.TechBuzz China by Pandaily is a weekly technology podcast focused on giving you a peek into what's buzzing within the tech community in China. It is co-hosted by Ying-Ying Lu and Rui Ma, who are both seasoned China watchers with years of experience working in the technology space in China. They uncover and contextualize unique insights, perspectives, and takeaways on headline tech news that don't always make it into English language coverage.Our co-hosts Ying-Ying Lu and Rui Ma break down the origin story of Ofo. Started by five Peking University graduates in bubbly 2014, the team was getting 4000 orders per day on the PKU campus alone, two months after launch. After being spotted by GSR Ventures investor Robin Luo, the rest is history. Today, ofo is at 32 million rides a day in over 200 cities. However, challenges continue to abound: repair costs, oversupply, and figuring out a viable business model in a heavy capex business.Listen to the newest episode of TechBuzz China and decide for yourself-- should bike-sharing, which has fundamentally changed how hundreds of millions of people move, remain as one of the four New Great Inventions?As always, you can find these stories and more at pandaily.com. Let us know what you think of the show by leaving us an iTunes review, like our Facebook page, and don't forget to tweet at us at @techbuzzchina to win some swag!

The internet age has brought with it what China's state media calls the country's “New Four Great Inventions”: high speed trains, scan-and-pay mobile payments, bike sharing, and ecommerce. This week’s episode is the first in a two-part story on bike sharing — told against a backdrop of Ofo, one of the two major Chinese players, pulling out of international markets. What happened? And most importantly, what is happening now? Listen to this week’s episode of TechBuzz China by co-hosts Ying-Ying Lu and Rui Ma, for a history lesson on Ofo! Guest speaker Karl Ulrich, the Vice Dean of Entrepreneurship and Innovation at the Wharton School, weighs in as well. TechBuzz China by Pandaily is a weekly technology podcast focused on giving you a peek into what’s buzzing within the tech community in China. It is co-hosted by Ying-Ying Lu and Rui Ma, who are both seasoned China watchers with years of experience working in the technology space in China. They uncover and contextualize unique insights, perspectives, and takeaways on headline tech news that don’t always make it into English language coverage. Our co-hosts Ying-Ying Lu and Rui Ma break down the origin story of Ofo. Started by five Peking University graduates in the bubbly tech world of 2014, the team was getting 4000 orders per day on the PKU campus alone just two months after launch. After being spotted by GSR Ventures investor Robin Luo, the rest is history. Today, Ofo is at 32 million rides a day in over 200 cities. However, challenges continue to abound: repair costs, oversupply, and figuring out a viable business model in a heavy capex business. Listen to the newest episode of TechBuzz China and decide for yourself: should bike-sharing, which has fundamentally changed how hundreds of millions of people move, remain as one of the four New Great Inventions? As always, you can find these stories and more at pandaily.com. Let us know what you think of the show by leaving us an iTunes review, like our Facebook page, and don't forget to tweet at us at @techbuzzchina to win some swag!  

Deals Alibaba has reportedly bought $3bn in shares of bicycle rental platform Ofo from venture firm GSR Ventures at a $10bn valuation, according to reports in China that cite comments made by a relative of GSR managing director Allen Zhu. E-commerce firm JD.com is looking to raise $2bn for its logistics services spinoff, JD Logstics, … Continue reading "22 January 2018 – Alibaba Buys $3bn in Shares of Ofo"

In March 2010, Google shut down its China-based search engine, and moved all traffic to its uncensored Hong Kong website, further enflaming the battle of censorship between the world’s largest search engine and the world’s most populous country. New media in China takes a variety of forms, from websites and blogs, to forums and online bulletin boards; this new form of communication has become a vital and popular tool for the average Chinese internet user to distribute and collect information on political, social, religious and business issues. Meanwhile, the Chinese Government is striving to reach a delicate balance on the role of new media—encouraging internet growth to have a more networked economy while exercising controls over people's access to regulated information. Kevin Fong, a special advisor to GSR Ventures, and Duncan Clark, the Chairman of BDA China, will discuss the policies and practices of new media in China. In an increasingly connected world, can China sustain its robust economic growth, while stifling internet freedom at home? And how should business leaders and investors adapt to work in an environment of economic opportunities and state regulations?